Dominari Holdings

PriceDominari Holdings

DOMH

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

Historical stock price chart and annual return over the past years

-65%

5 years

% Total

DOMH
-19%

5 years

Annual Return

DOMH